near-infrared spectrum. A porcine surgical model was used for this experiment. During data collection, the tissue is exposed to white light, without contrast materials, and the light absorbed or reflected from the tissue is analyzed. Utilizing liquid crystal technology, MCI-E generates real-time wavelength-specific imagery targeting tissue structures, and resulting detections are overlaid onto conventional high definition video. To evaluate detection performance, the contrast between the target tissue and surrounding tissues is quantified with the signal-to-noise ratio (SNR) and area under the ROC curve(AUC).
INTRODUCTION AND OBJECTIVES:
Cryoablation has assumed a growing role in the treatment of both primary, locallyrecurrent and metastatic tumors. However, reporting of procedural complications remains segregated by organ system and physician specialty. We examined urologic and non-urologic device-related adverse events during cryoablation reported to a national administrative database to understand the full spectrum of possible complications.
METHODS: We reviewed reports on cryoablation procedures submitted to the Food and Drug Administration (FDA) Manufacturer and User Facility Device Experience (MAUDE) database between 2015 and 2018. Cases were stratified by solid organ and device malfunction and a standardized MAUDE complication reporting system was used to evaluate direct patient impact. Logistic regression was used to compare complications between renal, prostate, and non-Urologic cases.
RESULTS: 406 cases were identified: 80 renal, 13 prostate, 42 non-urologic, and 271 without specified organ. 306 (75.4%) cases utilized the Galil system. Reports were found to be related to thermal injury, instrument malfunction/failure, computer failure, gas issue, or unrelated to the device. 68 (16.7%) of reported cases were not completed due to the complication. 5 deaths (1.2%) were appreciated (MAUDE 4), 93 (22.9%) major complications (MAUDE 3-4), and 32 (7.9%) minor complications (MAUDE 2). The manufacturer evaluated the device in 305 (75.1%) cases and accepted blame in 159. On univariate analysis, renal cases were associated with decreased odds of being reported with MAUDE 2-4 complications (OR [ 0.449, p[ 0.025). Conversely, prostate and non-urologic sites were insignificantly predictive of complication level.
CONCLUSIONS: Cryoablation for any tumor, urologic or not, is associated with a diverse set of procedure-related complications. Further study will be required as the usage of cryoablation continues to increase. Urologists performing cryoablation or referring patients for this therapy should be aware to maximize procedural efficacy and safety.
Source of Funding: None

MP20-03 DEVELOPMENT AND VALIDATION OF PATIENT SPECIFIC HYDROGEL KIDNEY PHANTOMS IN PREDICTING PARTIAL NEPHRECTOMY SUCCESS FOR COMPLEX RENAL MASSES
Pratik Gurung*, Rachel Melnyk, Shamroz Farooq, Hani Rashid, Guan Wu, Jean Joseph, Hani Awad, Ahmed Ghazi, Rochester, NY INTRODUCTION AND OBJECTIVES: Models generated from 3D printing technology are limited, by the lack of tissue realism, anatomical accuracy and vascular channels found within surgical target organs, allowing only limited tissue interaction. We present our unique technique, combining 3D printing and hydrogel casting to develop patient-specific kidney phantoms, which can be used as simulation platforms for preoperative rehearsals for cases with complex renal cancer.
METHODS: Model creation: Patient's DICOM files were imported into a segmentation software and converted to STL files to 3D-print injection molds. Individually fabricated tumors and hollow hilar structures were registered within the mold. Hydrogel (PVA) was injected Vol. 201, No. 4S, Supplement, Friday, May 3, 2019 THE JOURNAL OF UROLOGY Ò e283
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